Substance | Relationship Strength | Studies | Trials | Classes | Roles |
4-butyrolactone 4-Butyrolactone: One of the FURANS with a carbonyl thereby forming a cyclic lactone. It is an endogenous compound made from gamma-aminobutyrate and is the precursor of gamma-hydroxybutyrate. It is also used as a pharmacological agent and solvent.. tetrahydrofuranone : Any oxolane having an oxo- substituent at any position on the tetrahydrofuran ring.. gamma-butyrolactone : A butan-4-olide that is tetrahydrofuran substituted by an oxo group at position 2. | 3.02 | 4 | 0 | butan-4-olide | metabolite; neurotoxin |
chromium Chromium: A trace element that plays a role in glucose metabolism. It has the atomic symbol Cr, atomic number 24, and atomic weight 52. According to the Fourth Annual Report on Carcinogens (NTP85-002,1985), chromium and some of its compounds have been listed as known carcinogens.. chromium ion : An chromium atom having a net electric charge.. chromium atom : A chromium group element atom that has atomic number 24. | 2.49 | 2 | 0 | chromium group element atom; metal allergen | micronutrient |
alkenes [no description available] | 2.1 | 1 | 0 | | |
protolichesterinic acid protolichesterinic acid: HIV-1 reverse transcriptase inhibitor; isolated from the lichen Cetraria islandica; RN given refers to (2R-trans)-isomer; structure in first source | 7.52 | 2 | 0 | | |
alpha-methylene gamma-butyrolactone alpha-methylene gamma-butyrolactone : A butan-4-olide having a methylene group at the 3-position. | 2.49 | 2 | 0 | butan-4-olide | anti-ulcer drug; gastrointestinal drug |
lignans Lignans: A class of dibenzylbutane derivatives which occurs in higher plants and in fluids (bile, serum, urine, etc.) in man and other animals. These compounds, which have a potential anti-cancer role, can be synthesized in vitro by human fecal flora. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed) | 2.06 | 1 | 0 | | |
hydroxymatairesinol hydroxymatairesinol: a plant lignan from Norway spruce (Picea abies); structure in first source | 2.06 | 1 | 0 | | |
nephrosteranic acid nephrosteranic acid: structure in first source | 2.15 | 1 | 0 | gamma-lactone | |